相关实验视频

Updated: Jan 17, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

帕金森病下丘脑深度大脑刺激后的生存率:来自单一中心的25年经验

Sayooja Sachithanandan¹, Athul Sreelatha Sanjeev¹, Jissa Vinoda Thulaseedharan²

¹Comprehensive Care Centre for Movement Disorders, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, India.

Movement disorders clinical practice

|September 22, 2025

概括

在帕金森病患者的脑下核深度大脑刺激 (STN-DBS) 提供了13.1年的中位生存期. 较短生存时间的预测因素包括轴性特征和更高的药物需求,而良好的利沃多巴反应表明更长的生存时间.

科学领域:

神经学神经学
神经外科神经外科
老年学是一门学科.

背景情况:

对于帕金森病 (PD) 患者的长期存活情况,仅有有限的数据存在,这些患者在经过亚thalamic核深度大脑刺激 (STN-DBS) 后.
了解长期结果对于在STN-DBS后管理PD进展至关重要.

研究的目的:

估计STN-DBS后帕金森病患者的长期存活率.
在这个患者队列中确定生存的独立预测因素.

主要方法:

对186名接受STN-DBS和至少5年随访的PD患者进行了回顾性分析.
存活状态,死亡原因和死亡日期是通过与家庭成员的电话采访收集的.
分析了基线人口统计和临床特征,以确定生存预测因素.

主要成果:

在STN-DBS后的中位生存时间为13.1年.
渐进性PD,感染和心血管疾病是主要的死亡原因.
较短生存时间的预测因素包括基线姿势不稳定和步行功能障碍,较高的利沃多巴剂量和较高的UPDRS Part I分数;更好的利沃多巴反应预测了更长的生存时间.

结论:

对于帕金森病患者来说,STN-DBS提供了大约13年的中位生存期.
轴性特征,认知能力下降,勒沃多巴反应不佳,以及在基线时的高药物需求与生存率降低有关.
结果可以为外科候选人选择和长期护理策略提供信息,特别是在资源有限的环境中.

关键词:

帕金森病的疾病.死亡原因死亡原因深度大脑刺激刺激大脑长期生存率长期生存率预测者预测者预测者

更多相关视频

Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation

Microelectrode Guided Implantation of Electrodes into the Subthalamic Nucleus of Rats for Long-term Deep Brain Stimulation

Published on: October 2, 2015

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models

Published on: August 12, 2018

相关概念视频

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...